What is RNAC's dilution risk score?

RNAC has a latest available DilutionScore record of 33/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for RNAC, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for RNAC?

DilutionWatch tracks 25 SEC filing types for RNAC including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect RNAC shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For RNAC, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for RNAC tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for RNAC. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

RNAC Dilution Risk Score: 33/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

10

📊 Float Risk

70

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for RNAC.

🔔 Track RNAC — Get forecast alerts →

Market Data

Market Cap$221.54M

Shares Outstanding30.26M

Float9.57M

Cash$159.09M

Debt$52.85M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 45.4% shares (2026Q1 vs prior)

83 institutional holders · 7.68M shares

#1 Squarepoint Ops LLC 2.24M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 815.2K shares

#3 FMR LLC 799.7K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.84M

Days to Cover14.9

% of Float19.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2016-12-31

4 INSIDER TRANSACTION 2026-04-06

4 INSIDER TRANSACTION 2026-03-13

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual RNAC Dilution Snapshot

Cartesian Therapeutics, Inc. (RNAC) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 196,850.
Recent SEC activity tracked for RNAC: xbrl on 2026-06-30; 4 on 2026-04-06; 4 on 2026-04-06.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.